Haemonetics Corporation (HAE)

Return on assets (ROA)

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net income	US$ in thousands	167,679	117,558	115,401	43,375	79,469
Total assets	US$ in thousands	2,450,950	2,195,590	1,934,820	1,859,730	1,819,920
ROA		6.84%	5.35%	5.96%	2.33%	4.37%

March 31, 2025 calculation

ROA = Net income ÷ Total assets
= $167,679K ÷ $2,450,950K
= 6.84%

Haemonetics Corporation's Return on Assets (ROA) has shown fluctuations over the past five years. In March 2021, the ROA stood at 4.37%, demonstrating the company's ability to generate 4.37 cents of profit for every dollar of assets it owns. However, there was a decrease in ROA by March 2022, dropping to 2.33%, indicating a decline in profitability and efficiency in asset utilization.

By March 2023, the ROA experienced a significant rebound, reaching 5.96%, suggesting that the company improved its profitability and asset management strategies. This positive trend continued in March 2024, with ROA standing at 5.35%, although slightly lower than the previous year.

It is worth noting that no ROA data is available for March 31, 2025, which could indicate a change in reporting or data availability. Overall, a higher ROA indicates better efficiency in utilizing assets to generate profits, while a lower ROA may signify inefficiency or declining profitability.